Morris Financial Concepts’s Vertex Pharmaceuticals VRTX Stock Holding History

Morris Financial Concepts’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$266K	Buy	536 +6	+1%	+$2.66K	0.08%	124
2026 Q1	$237K	Buy	530 +23	+5%	+$10.7K	0.08%	123
2025 Q4	$230K	Sell	507 -4	-0.8%	-$1.72K	0.08%	125
2025 Q3	$200K	Buy	511 +7	+1%	+$2.92K	0.07%	135
2025 Q2	$224K	Sell	504 -10	-2%	-$4.61K	0.09%	125
2025 Q1	$249K	Buy	514 +9	+2%	+$4.19K	0.1%	113
2024 Q4	$203K	Sell	505 -16	-3%	-$7.42K	0.09%	121
2024 Q3	$242K	Buy	+521	New	+$250K	0.1%	108

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morris Financial Concepts's VRTX Position: Q2 2026 in Review

Morris Financial Concepts increased its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q2 2026, buying an estimated $2.66K and bringing the position to 536 shares worth $266K. The position accounts for 0.08% of the portfolio, ranked #124.

Morris Financial Concepts first reported a position in VRTX in Q3 2024 and has held it in 8 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Morris Financial Concepts held 536 shares of Vertex Pharmaceuticals worth $266K as of Q2 2026.
Morris Financial Concepts bought 6 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.66K.
Vertex Pharmaceuticals made up 0.08% of Morris Financial Concepts's portfolio in Q2 2026, its #124 holding.
Morris Financial Concepts first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Morris Financial Concepts's 13F filing for Q2 2026, filed 29 Jul 2026.